Over the last 7 days, the Biotech industry has dropped 2.4%, driven by Celltrion declining 2.6%. On the other hand Hugel is actually up 5.0%. In the past year, the industry has gained 3.0%. Earnings are forecast to grow by 49% annually.
Has the South Korean Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 29 May 2024 | ₩79.6t | ₩9.8t | -₩638,498,171,658.00 | 22.2x | -124.7x | 8.1x |
Fri, 26 Apr 2024 | ₩78.9t | ₩9.6t | -₩574,854,220,678.00 | 22x | -137.3x | 8.2x |
Sun, 24 Mar 2024 | ₩84.7t | ₩9.6t | -₩603,302,771,467.00 | 45.3x | -140.5x | 8.9x |
Tue, 20 Feb 2024 | ₩75.0t | ₩9.7t | -₩534,696,541,747.00 | 63.6x | -140.3x | 7.7x |
Thu, 18 Jan 2024 | ₩74.4t | ₩9.7t | -₩537,261,689,777.00 | 62x | -138.5x | 7.6x |
Sat, 16 Dec 2023 | ₩58.9t | ₩10.1t | -₩311,749,314,637.00 | 28.3x | -188.9x | 5.8x |
Mon, 13 Nov 2023 | ₩55.8t | ₩10.2t | -₩236,884,460,909.00 | 30.2x | -235.5x | 5.5x |
Wed, 11 Oct 2023 | ₩54.5t | ₩10.2t | -₩239,053,318,689.00 | 27.2x | -227.8x | 5.3x |
Fri, 08 Sep 2023 | ₩57.6t | ₩10.2t | -₩340,060,706,949.00 | 33.5x | -169.4x | 5.7x |
Sun, 06 Aug 2023 | ₩58.2t | ₩10.3t | -₩151,534,704,579.00 | 29.1x | -384.2x | 5.7x |
Tue, 04 Jul 2023 | ₩57.7t | ₩10.3t | -₩151,534,704,579.00 | 27.5x | -381x | 5.6x |
Thu, 01 Jun 2023 | ₩63.3t | ₩10.4t | -₩124,041,464,499.00 | 35.3x | -510.2x | 6.1x |
Sat, 29 Apr 2023 | ₩60.0t | ₩11.0t | ₩317.9b | 24.4x | 188.8x | 5.5x |
Mon, 27 Mar 2023 | ₩56.5t | ₩10.8t | ₩436.1b | 23.3x | 129.6x | 5.2x |
Wed, 22 Feb 2023 | ₩59.1t | ₩11.3t | ₩968.6b | 25.7x | 61x | 5.2x |
Fri, 20 Jan 2023 | ₩59.1t | ₩11.4t | ₩685.0b | 24x | 86.3x | 5.2x |
Sun, 18 Dec 2022 | ₩62.2t | ₩10.8t | ₩197.3b | 26.6x | 315.2x | 5.7x |
Tue, 15 Nov 2022 | ₩63.7t | ₩10.8t | ₩343.5b | 21x | 185.3x | 5.9x |
Thu, 13 Oct 2022 | ₩53.9t | ₩10.8t | ₩371.7b | 20.7x | 145.1x | 5x |
Sat, 10 Sep 2022 | ₩64.8t | ₩10.8t | ₩492.9b | 23.8x | 131.6x | 6x |
Mon, 08 Aug 2022 | ₩73.6t | ₩10.7t | ₩597.6b | 26.4x | 123.1x | 6.9x |
Wed, 06 Jul 2022 | ₩66.3t | ₩10.7t | ₩597.6b | 24x | 111x | 6.2x |
Fri, 03 Jun 2022 | ₩69.0t | ₩10.6t | ₩680.3b | 27.8x | 101.4x | 6.5x |
Sun, 01 May 2022 | ₩71.9t | ₩10.0t | ₩866.3b | 27.7x | 83x | 7.2x |
Tue, 29 Mar 2022 | ₩74.4t | ₩9.9t | ₩882.0b | 29.3x | 84.3x | 7.5x |
Thu, 24 Feb 2022 | ₩71.4t | ₩9.4t | ₩783.3b | 33.8x | 91.2x | 7.6x |
Sat, 22 Jan 2022 | ₩79.0t | ₩9.4t | ₩787.4b | 33.8x | 100.4x | 8.4x |
Mon, 20 Dec 2021 | ₩97.7t | ₩9.4t | ₩780.1b | 40.8x | 125.2x | 10.4x |
Wed, 17 Nov 2021 | ₩97.9t | ₩9.2t | ₩986.0b | 33.2x | 99.3x | 10.6x |
Fri, 15 Oct 2021 | ₩98.7t | ₩9.2t | ₩986.0b | 38.4x | 100.1x | 10.7x |
Sun, 12 Sep 2021 | ₩116.5t | ₩9.3t | ₩946.2b | 43.2x | 123.2x | 12.5x |
Tue, 10 Aug 2021 | ₩118.4t | ₩9.3t | ₩909.7b | 51.2x | 130.1x | 12.7x |
104x
How does South Korean Biotech compare with similar industries?
KR Market | -0.56% | |
Healthcare | -2.58% | |
Biotech | -2.39% | |
Biotech | -2.39% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A950160 Kolon TissueGene | ₩14.24k | 16.7% +₩151.5b | 46.5% | n/a | |
A304360 S.Biomedics | ₩41.55k | 30.3% +₩110.3b | 195.9% | PS37.4x | |
A115450 HLB TherapeuticsLtd | ₩8.40k | 18.1% +₩101.8b | 52.3% | PS12.3x | |
A086900 Medy-Tox | ₩141.10k | 8.5% +₩74.7b | -42.4% | PE108.2x | |
A310210 Voronoi | ₩38.45k | 12.3% +₩72.7b | 4.2% | PB8.2x |